Endostart Gains CE Mark for Endorail

Endostart, a medical device company specializing in gastrointestinal endoscopy solutions, today has obtained a CE marking for the expanded use of its flagship product, Endorail. This extends Endorail’s application to enteroscopy, making this challenging procedure more accessible and widely available, significantly advancing gastrointestinal endoscopy and improving patient care.
 
“We are thrilled to obtain the CE mark for small bowel procedures. This milestone has the potential to be a game-changer in managing small bowel diseases. It highlights our commitment to innovation and our dedication to developing tools that enhance patient care,” said Dr. Alessandro Tozzi, co-founder and CEO at Endostart.
 
Endorail leverages a magnetic balloon system, providing enhanced endoscope control in the small and large bowel. The system uses a magnetically anchored balloon to stabilize and guide the endoscope, reducing looping and improving maneuverability. 
 
This innovation simplifies the colonoscopy process and now improves enteroscopy by aiding both balloon-assisted and push enteroscopy procedures. Endorail features a user-friendly design that is aimed at empowering physicians to improve procedural performance, ensuring more effective and efficient outcomes while reducing the healthcare costs associated with prolonged or incomplete procedures.
 
Endorail is already available in Italy, UK, and France. With this new CE marking, Endorail offers a solution for enteroscopy, which is critical for diagnosing and treating small bowel conditions, such as cancer, bleeding, and chronic inflammatory diseases. 
 
“Currently, therapeutic enteroscopy is only available at a limited number of hospitals and few endoscopists are trained to perform these complex procedures. The goal for Endostart is to make enteroscopy more accessible on a large scale, including community hospitals,” said Christopher Rowland, chairman of the board at Endostart.
 
“Magnetic balloon-assisted enteroscopy has the potential to transform procedures, not only for small bowel conditions like bleeding or polyps, but also for challenging treatments such as Endoscopic Retrograde CholangioPancreatography (ERCP) in altered anatomy,” added Prof. Alessandro Repici, director of the Digestive Endoscopy Unit atHumanitas Research Hospital, Milan, Italy.
 
Endostart will showcase an updated version of Endorail at the UEG Week conference in Vienna, Austria, from October 12–15, highlighting new colonoscopy and enteroscopy features.